Gene therapy for SCID—a complication after remarkable progress
- 1 October 2002
- journal article
- Published by Elsevier in The Lancet
- Vol. 360 (9341) , 1185-1186
- https://doi.org/10.1016/s0140-6736(02)11290-6
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Murine Leukemia Induced by Retroviral Gene MarkingScience, 2002
- Sustained Correction of X-Linked Severe Combined Immunodeficiency by ex Vivo Gene TherapyNew England Journal of Medicine, 2002
- Hematopoietic stem cell transplantation for severe combined immunodeficiency in the neonatal period leads to superior thymic output and improved survivalBlood, 2002
- Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 DiseaseScience, 2000
- Long-Term Chimerism and B-Cell Function After Bone Marrow Transplantation in Patients With Severe Combined Immunodeficiency With B Cells: A Single-Center Study of 22 PatientsBlood, 1999
- Hematopoietic Stem-Cell Transplantation for the Treatment of Severe Combined ImmunodeficiencyNew England Journal of Medicine, 1999
- LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processesGenes & Development, 1998